More about Alkyl Amines Chemicals Limited
Fundamentals for Alkyl Amines Chemicals Limited
Regulatory Filings for Alkyl Amines Chemicals Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Fundamentals for Alkyl Amines Chemicals Limited
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.
Revenue projections:
With ALKYLAMINE's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 31.030666 |
| debtToEquity | 0.000000 |
| earningsGrowth | -0.035000 |
| revenueGrowth | -0.046000 |
| grossMargins | 0.454280 |
| operatingMargins | 0.139750 |
| trailingEps | 35.330000 |
| forwardEps | 47.833330 |
Alkyl Amines Chemicals Limited's low earnings and revenue growth suggest shrinking profits. This negative trend could indicate that the company is struggling to maintain its financial performance and may face challenges ahead.
ALKYLAMINE's negative gross and operating margins suggest the company is not generating profit from either its production process or day-to-day operations. This could signal cost overruns or difficulties in maintaining revenue levels.
With ALKYLAMINE's forward EPS higher than its trailing EPS, the company is expected to be more profitable in the current financial year. This signals confidence in ALKYLAMINE's growth potential, as improved earnings are forecasted compared to the prior year's performance.
Price projections:
The price of Alkyl Amines Chemicals Limited currently aligns with projections, offering no clear risks or opportunities. This situation suggests stability in the stock's performance, leading investors to await further developments before making strategic decisions.
Insider Transactions:
There were 6 Alkyl Amines Chemicals Limited sales transactions, at market price of 1811.2333374023438.6 separate transactions to buy ALKYLAMINE were completed, while market price hovered around 1675.383321126302.There is no discernible trend in insider transactions, making it hard to determine whether these actions signal positive or negative developments within the company.
Recommendation changes over time:
The recent sell bias from analysts on ALKYLAMINE suggests investors should be cautious. However, it's a good idea to base decisions on a broader range of market indicators to gain a more complete and accurate view of the stock's potential performance in the near term.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape